DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Pate…
Drug Patent Expirations for the Week of February 25, 2024 Read Post »
Annual Drug Patent Expirations for VELSIPITY Velsipity is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug VELSIPITY appeared first on DrugPa…
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. There are four…
The post New patent expiration for Mylan Speciality drug DYMISTA appeared first…
New patent expiration for Mylan Speciality drug DYMISTA Read Post »
This chart shows the generic firms that had the most successful drug patent challenges last year. Companies that successfully challenge patents on branded drugs are granted six months of generic…
The post Most drug patent challenges last year appeared …
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-two patents…
The post New patent for Deciphera Pharms drug QINLOCK appeared first …
This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Brazil? Read Post »
Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Dr…
Annual Drug Patent Expirations for ZURZUVAE Zurzuvae is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Biogen Inc drug ZURZUVAE appeared first on DrugPatentWa…
Annual Drug Patent Expirations for FILSUVEZ Filsuvez is a drug marketed by Amryt and is included in one NDA. It is available from one supplier. The generic ingredient in FILSUVEZ…
The post New patent for AMRYT drug FILSUVEZ appeared first on DrugPatent…
Annual Drug Patent Expirations for PIQRAY Piqray is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug PIQRAY appeared first on DrugPatentWa…
Get new actionable insights and updates from BiotechBlog
